5 Of The Most Captivating Christmas Decoration Displays In Sydney
We’re usually all business here at Business Review Australia, but we’re lightening up this holiday season with some fun pieces. Below are a few places you can take your family to enjoy the holiday, and work on the work/life balance you’ve been promising to be better about since the New Year of 2014.
Christmas Light Forest: Pitt Street Mall
Technology is playing a big part in Sydney’s Christmas decor this year. One of the coolest examples is the Christmas Light Forest at Pitt Street Mall. Visitors can download a free smartphone app that allows them to interact with and control the colour change sequencing. The trees are suspended from wiring and are made of thousands of LED lights that integrate with the free app.
Head to the City after sunset and watch in wonder as the Town Hall facade springs to life with vivid light projections every evening. New in 2014, digital projections will also feature on buildings at the King Street entrance to Pitt Street Mall, transforming the area into a magical landscape.
Interactive Christmas Tree: Martin Place
A touchpad kiosk near the interactive Christmas tree in Martin Place allows visitors to interact and control the colour settings of the LED tree decorations. But that’s not all. The “ribbon” circling the tree will display messages that you can text (with the number 0427840851) or send using the hashtag #sydxmastree. Can’t wait to see what next year’s interactions bring us.
Lights Of Christmas: St. Mary’s Cathedral
St. Mary’s Cathedral is already a beautiful building, but when it’s “dressed” for the holidays it is stunning. You won’t see any actual decorations on the facade during the day, but it lights up the city at night. AGB Events, illuminates the cathedral’s 75-metre front with digital imagery and animation. It’s all set to a specially commissioned soundtrack and narration. 2014 signals St. Mary’s fifth year of putting on
Australia’s Largest Christmas Tree: Westfield Sydney
If you had all the LEGO bricks you wanted, what would you build? Ryan McNaught, LEGO Certified Professional, decided to build the biggest Christmas tree in Australia. How big is it, you ask? Well, it’s 10 metres tall and made of nearly half a million LEGO bricks—the biggest LEGO tree ever in the Southern Hemisphere.
But the tree isn’t all: there’s a life-size Santa and sleigh. Kids are sure to love the display, but I don’t know many adults who would shy away from the fun of LEGO.
Tweet @BizReviewAU with your favourite #SydXMAS decorations!
Seo JungJin: Who is EY’s World Entrepreneur of 2021?
Seo JungJin, founder of biopharma firm Celltrion, which most recently developed an antibody treatment for COVID-19, has been named the EY World Entrepreneur of the Year 2021, becoming the first South Korean in the award’s 21-year history.
Regarded as one of the world’s most prestigious business awards program for entrepreneurs, the EY Entrepreneur of the Year celebrates visionary and innovative leaders from across 60 countries who are transforming the world and fostering growth.
JungJin, who is now honoroary chairman of Celltrion Group, was up against a worthy cast of entrepreneurial competitors, taking the crown from among 45 award winners across 38 countries and territories.
Speaking during the virtual event, JungJin described his own interpretation of entrepreneurship as something that brings together “a group of people toward a common vision, embracing challenges as opportunities and committing oneself to contribute to the greater good”.
Why was JungJin crowned King Entrepreneur?
A South Korean native and now 63 years of age, JungJin founded biopharmaceutical firm Celltrion in 2003. In the nearly two decades since its founding, Celltrion has lived up to its goal of advancing health and welfare for all by developing ground-breaking drugs to treat autoimmune disease, various forms of cancer and, most recently, COVID-19.
The company, which JungJin started with just US$45,000 and five of his colleagues, has since growth to more than 2,1000 employees with sales permits in more than 90 countries and revenues exceeding US$1.69bn.
According to the panel, JungJin’s story is a shining example of the power of an unstoppable entrepreneur to change the world with the pandel moved by both his incredible story and his purpose-driven leadership, innovative mindset and entrepreneurial spirit.
Described by the chair of the EY judging panel Rosaleen Blair as “representing everything an unstoppable should be” from taking on the world’s biggest health care challenges to consistently creating long-term value for his company, JungJin’s story is one of incredible tenacity and perseverance that the judging panel felt most represented the entrepreneurial spirit.
“He’s taken breathtaking risks, both personal and professional, to found Celltrion and grow it into one of the world’s leading biopharmaceutical companies,” says Stasia Mitchell, EY Global Entrepreneurship Leader. “His passion for creating affordable, life-saving health care and flair for tackling global problems has led to many treatments that have helped millions of people worldwide and was especially evident this past year through the creation of a COVID-19 antibody treatment.”
How did JungJin get there?
JungJin's entrepreneurial journey started at an early age when he worked as a taxi driver to get himself through Konkuk University in Seoul, South Korea. After studying industrial engineering, he rose through the ranks of Daewoo Motor Co. before losing his job amid the carmaker’s financial troubles following the 1997 Asian economic crisis.
Following this, JungJin started collaborating with colleagues to explore business opportunities in different industries, though none delivered lasting success. The turning point came after he attended a talk hosted by renowned scholars, which inspired him to focus on the biopharmaceutical sector.
And so he founded Celltrion with just US$45,000 of his savings. The launch of Remsima, credited with being the world's first antibody biosimilar, quickly moved Celltrion up the ranks of the country's fairly underdeveloped pharmaceutical sector. Celltrion followed this success with the launch of drugs for breast cancer and lymphoma that today are being used worldwide.
With ambitions to be the world’s first in different areas, Celltrion has pioneered numerous uncharted areas to great success over the past two decades, most recently responding to the global pandemic by successfully developing an antibody treatment for COVID-19 and working to ensure a timely supply of the safe and effective treatment.
“When I first started, my vision was to help patients gain access to safe, effective and affordable medicines and thereby enhance the quality of people’s lives,” explains JungJin. “The success of Celltrion has enabled me to expand on this while finding new ways to fuel my entrepreneurial drive.”